Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral Melanoma

Guardado en:

Detalles Bibliográficos
Publicado en:	Cancer Management and Research vol. 17 (2025), p. 905
Autor principal:	Zhang, Jiaran
Otros Autores:	Tian, Huichun, Mao, Lili, Li, Caili, Wei, Xiaoting, Gu, Junjie, Wang, Xuan, Zhou, Li, Lian, Bin, Tang, Bixia, Xieqiao Yan, Li, Siming, Cui, Chuanliang, Chi, Zhihong, Xinan Sheng, Guo, Jun, Lu, Si
Publicado:	Taylor & Francis Ltd.
Materias:	Eastern Cooperative Oncology Group Peking University Comorbidity Patients Medical prognosis Antibodies Clinical medicine Cancer therapies Mutation Response rates Clinical trials Oncology Melanoma Performance evaluation Dehydrogenases Angiogenesis
Acceso en línea:	Citation/Abstract Full Text + Graphics Full Text - PDF
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!